About OMNIA
OMNIA brings together researchers, clinicians and industry partners to build
a more detailed understanding of nanoparticle behaviour in cancer.
By combining material design with spatial biology and interpretable AI,
we aim to establish evidence that can guide the development of safer and more effective nanomedicines.
OUR MISSION
Connecting design and biological evidence
Our mission is to connect nanomaterial design with biological evidence at cellular and tissue scales. We will combine complementary experimental and computational approaches, establish shared methods and support knowledge exchange so that findings can be compared and built upon across laboratories.
The Challenge
A complex environment
A tumour contains different cancer cells alongside immune cells, blood vessels and supporting tissue. These local environments can influence whether a nanoparticle reaches its target and what happens after it arrives. Understanding these interactions requires measurements that connect nanoparticle properties with the identity, location and response of the cells they encounter.
OUR OBJECTIVES
From materials to meaningful insights
Develop and characterise a harmonised panel of nanoparticles with controlled physical and chemical properties.
Investigate nanoparticle interactions in advanced three-dimensional cancer models and preclinical tumour models.
.png "Icon-1-.png")
Use spatial multi-omics and single-cell analyses to relate nanoparticle localisation to molecular and cellular responses.
Use spatial multi-omics and single-cell analyses to relate nanoparticle localisation to molecular and cellular responses.
.png "Icon-2-.png")
Strengthen shared expertise and support the responsible use of project methods and findings across research, clinical and industrial communities.
WHY WORK TOGETHER
A multidisciplinary consortium
The questions OMNIA addresses span materials science, biology, imaging, computation and translation. Our consortium combines these capabilities within a joint programme, allowing methods to be developed, compared and applied across institutions. Staff exchanges support this work by bringing researchers into direct contact with the people and facilities behind each approach.
WHY WORK TOGETHER
Evidence for safer
and more effective nanomedicines
OMNIA aims to deliver transferable methods and evidence linking nanoparticle design to biological behaviour. Its research will support more reproducible experiments and better-informed decisions about which materials, targeting strategies and analytical approaches warrant further development.
WHY WORK TOGETHER
Led by Ankara University
OMNIA is coordinated by Prof. Dr. Açelya Yılmazer Aktuna at Ankara University, Türkiye.
Information
Project Detail
Full Project Title
| Orchestrating Multi-Omic Nanomedicine Insights with AI and Spatial Biology–Driven Innovation and Training for Hard-to-Treat Cancers |
|---|---|
Programme | Horizon Europe — Marie Skłodowska-Curie Actions Staff Exchanges |
Grant Agreement
| 101299913 |
Project Dates
| 1 September 2026 – 31 August 2030 |
Power and Battery | €1,803,600 |
Processor | Ankara University, Türkiye |
OMNIA
Connecting nanomedicine, spatial biology & AI.
Europen research. Global connections.
Quick Links
Legal
Privacy
Terms
Cookies
Site
EU Funding Acknowledgement
OMNIA is funded by the European Union under the Horizon Europe Marie Skłodowska-Curie Actions Staff Exchanges programme, Grant Agreement No. 101299913.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.
© 2026 OMNIA Project All